Jinhai Medical Technology Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-102.00
-106.00
-18.00
4.00
0.00
8.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-12.00
-20.00
-2.00
-6.00
25.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-36.00
-21.00
-10.00
26.00
19.00
39.00
Cash Flow from Investing Activities
21.00
-53.00
-39.00
-7.00
-16.00
-34.00
Cash Flow from Financing Activities
161.00
19.00
80.00
-21.00
-27.00
-21.00
Net Cash Inflow / Outflow
150.00
-56.00
28.00
-4.00
-23.00
-17.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
-1.00
-2.00
-1.00
0.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jinhai Medical Technology Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-102.400300398135
205.037570856011
-307.00
-149.94%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.9870763022873
-188.302575846956
177.00
93.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-36.8263986748218
158.296681005645
-194.00
-123.26%
Cash Flow from Investing Activities
21.0206420174007
134.290880908755
-113.00
-84.35%
Cash Flow from Financing Activities
161.494378893831
-138.068316776041
299.00
216.97%
Net Cash Inflow / Outflow
150.01447107621
155.587205623227
-5.00
-3.58%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.32584883980003
1.06796048486686
3.00
305.06%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -68.64% vs -111.42% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-36.83
-21.84
-68.64%






